Key result
Antiplatelet therapy is linked to ~32% bleeding incidence, consisting mostly of nuisance bleeding.
Why the study?
Medical practitioners often advise patients on antiplatelet therapy to stop or alter medications before invasive procedures due to fear of excessive bleeding, but the incidence of gum bleeding in this population was not well characterized.
Cross-Sectional (n=120)
No
The study suggests that most dental interventions can be safely performed without interrupting antiplatelet therapy, as bleeding is generally manageable.
Answers are grounded in this paper and cite their sources.
Dental procedures may proceed without antiplatelet interruption; observational data leave open need for randomized confirmation before practice change.
Introduction: Medical practitioners often advise patients on antiplatelet therapy to either stop or alter their medications prior to invasive surgical procedure because of fear of excessive and uncontrolled bleeding. Objectives: The main objective of the study is to analyse the incidence of gum bleeding in patients taking antiplatelet therapy among local population of Pakistan Material and methods: This descriptive study was conducted in Saddique Family Hospital Gujranwala during June 2020 to December 2020. After permission from hospital ethical committee, total 120 patients meeting the inclusion and exclusion criteria will be enrolled in the study from Saddique Family Hospital Gujranwala. Detailed history and physical examination will be done to meet the inclusion and exclusion criteria. Informed consent will be obtained. Internal bleeding included hematoma, epistaxis, vaginal bleeding, melena, hematemesis, eye bleeding, and haematuria. Results: The data was collected from 120 patients. The mean age was 35.67±2.56 years. The mean BT was 19.5 ± 5.2 min, ranging from 5 min to more than 20 min. The incidence of bleeding was 32%. Seventeen patients had a BT longer than 20.5 min and less than 26 min: 5 nuisance bleeding and 1 internal bleeding (mild hematuria) which stopped after discontinuation of platelet inhibitory agents. Conclusion: It is concluded that available evidence suggests that most dental interventions can be safely performed without the interruption of antithrombotic therapy.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2022) conducted a cross-sectional in Patients taking antiplatelet therapy (n=120). Antiplatelet therapy was evaluated on Incidence of bleeding. Among patients taking antiplatelet therapy, the overall incidence of bleeding was 32%, with most cases being nuisance bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: